About APCI

APCI logo

Not a member?
Join today!

(800) 532-2724

Since 1984, APCI has been the ‘united voice of independent pharmacy’

APCI began as a small buying group for a limited number of independent pharmacies in central Alabama. Since that time, the cooperative has grown to more than 1,800 members pharmacies in 26 states, and provides its members with a wide range of products and services.

Our mission is to represent the economic and professional interests of independent pharmacies by providing leadership, vision, and a collective voice for our members in the healthcare marketplace. Our goal is to level the playing field for our member pharmacies by providing innovative, targeted programs to benefit our entire membership.

5

Feb

2016

Prime Therapeutics: Processing Update for Nexium® for Covered Persons of Blue Cross and Blue Shield of Alabama

Effective: February 12, 2016

Dear Valued Provider, Effective February 12, 2016, Blue Cross and Blue Shield of Alabama (BCBSAL) will be changing Nexium® to a Tier 3 covered drug*. This change is due to more generic versions of Nexium® (esomeprazole magnesium) being available on the market. If a Participating Pharmacy submits a claim for Nexium® for a Covered Person, the claim will process at a Tier 3 copayment compared to Tier 1 copayment for esomeprazole magnesium.

5

Feb

2016

PerformRx: Compound Kits Changes

Effective: February 12, 2016

The most common compounding kits are for omeprazole and lansoprazole oral solution and Magic Mouthwash. Pharmacies should continue to compound prescription without using the NDC associated with these Compound Kits. Prescription compounding kits contain pre-measured ingredients and other materials used to create a specific compounded product. A few manufacturers produce these kits, and each kit is identified under a single National Drug Code (NDC). NDCs for these kits are listed in the Food and Drug Administration’s (FDA’s) drug database with a marketing status of "Unapproved." Therefore PerformRx and its claims processor will no longer process claims using NDC associated with these Compound Kits.

5

Feb

2016

Tmesys: Notification of Update to Tmesys MAC Pricing

Dear Pharmacy Provider, Pursuant to state MAC regulations, please consider this to be notification that Tmesys has reviewed and instated a new MAC pricing list. Tmesys MAC pricing is determined by a third party vendor, Glass Box Analytics LLC, using the Predictive Acquisition Cost (PAC) model. PAC pricing uses the following sources: industry MAC Benchmarks, published price lists, existing pricing benchmarks, behavioral metrics, and supply/demand measures. PAC pricing also uses as a "source", survey based drug acquisition costs obtained from CMS on the national level and pharmacy level pricing information as reported to state agencies from the following states: Arkansas, Colorado, Idaho, Louisiana, and Oregon. Helios strives to ensure compliance with all state legislative and regulatory requirements related to the provision of pharmacy and ancillary services. Therefore, to receive information pursuant to, and compliant with these regulations, interested Tmesys network pharmacies should fill out the MAC Inquiry Form and Non-Disclosure Agreement that can be accessed via the Helios website and email the completed forms to MACresolution@helioscomp.com. Thank you, Tmesys

First757759Last